Diabetes-mediated IL-17A enhances retinal inflammation, oxidative stress, and vascular permeability.
Cell Immunol
; 341: 103921, 2019 07.
Article
en En
| MEDLINE
| ID: mdl-31076079
Diabetic retinopathy is a prevailing diabetes complication, and one of the leading causes of blindness worldwide. IL-17A is a cytokine involved in the onset of diabetic complications. In the current study, we examined the role of IL-17A in the development of retinal inflammation and long-term vascular pathology in diabetic mice. We found IL-17A expressing T cells and neutrophils in the retinal vasculature. Further, the IL-17A receptor was expressed on Muller glia, retinal endothelial cells, and photoreceptors. Finally, diabetes-mediated retinal inflammation, oxidative stress, and vascular leakage were all significantly lower in IL-17A-/- mice. These are all clinically meaningful abnormalities that characterize the onset of diabetic retinopathy.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Permeabilidad Capilar
/
Interleucina-17
/
Células Endoteliales
/
Diabetes Mellitus Experimental
/
Retinopatía Diabética
/
Células Ependimogliales
Límite:
Animals
Idioma:
En
Revista:
Cell Immunol
Año:
2019
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Países Bajos